Bradley Saenger
Directeur Financier/CFO chez TONIX PHARMACEUTICALS HOLDING CORP.
Fortune : 16 $ au 31/05/2024
Profil
Bradley Saenger is currently a Director at Tonix Pharma Holdings Ltd.
and the Chief Financial Officer & Treasurer at Tonix Pharmaceuticals Holding Corp.
He previously worked as an Associate Director-Accounting at Vertex Pharmaceuticals, Inc. from 2011 to 2012 and as a Manager-Corporate Accounting & Consolidations at Alere, Inc. from 2007 to 2011.
Mr. Saenger completed his undergraduate degree at the University of South Africa.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/04/2024 | 99 ( 0,00% ) | 16 $ | 31/05/2024 |
Postes actifs de Bradley Saenger
| Sociétés | Poste | Début |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Directeur Financier/CFO | 01/02/2016 |
| Tonix Pharma Holdings Ltd. | Directeur/Membre du Conseil | 01/11/2015 |
Anciens postes connus de Bradley Saenger
| Sociétés | Poste | Fin |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | 01/12/2012 |
| ALERE INC | Directeur Financier/CFO | 01/09/2011 |
Formation de Bradley Saenger
| University of South Africa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Alere, Inc.
 Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
| Tonix Pharma Holdings Ltd. |
